US Stock MarketDetailed Quotes

MNKD MannKind

Watchlist
  • 5.060
  • -0.160-3.07%
Close Mar 26 16:00 ET
  • 5.050
  • -0.010-0.20%
Pre 07:01 ET
1.54BMarket Cap50.60P/E (TTM)

About MannKind Company

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Company Profile

SymbolMNKD
Company NameMannKind
Listing DateJul 28, 2004
Issue Price14.00
Founded1991
CEOMr. Michael E. Castagna, Pharm.D.
MarketNASDAQ
Employees407
Fiscal Year Ends12-31
Address1 Casper Street
CityDanbury
ProvinceConnecticut
CountryUnited States of America
Zip Code06810
Phone1-818-661-5000
Websitehttp://www.mannkindcorp.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael E. Castagna, Pharm.D.
  • Director and Chief Executive Officer
  • 7.07M
  • Christopher B. Prentiss
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Burkhard Blank,M.D.
  • Executive Vice President, Research and Development and Chief Medical Officer
  • --
  • Lauren M. Sabella
  • Executive Vice President, Operations
  • 1.91M
  • Sanjay R. Singh
  • Executive Vice President, Technical Operations
  • --
  • Dr. Stuart A. Tross, PhD
  • Executive Vice President, Human Resources
  • 2.22M
  • Dominic Marasco
  • President, Endocrine Business Unit
  • --
  • Dr. James S. Shannon, M.D.,M.R.C.P.
  • Chairman of the Board
  • 255.64K
  • Steven B. Binder
  • Director
  • 2.34M
  • Jennifer Grancio
  • Independent Director
  • 221.73K
  • Christine A. Mundkur
  • Independent Director
  • 226.73K
  • Ronald J. Consiglio
  • Independent Director
  • 241.73K
  • Anthony C. Hooper
  • Independent Director
  • 233.14K
  • Dr. Sabrina Kay, PhD
  • Independent Director
  • 221.73K
  • Dr. Michael A. Friedman M.D.
  • Independent Director
  • 229.23K
  • Dr. David B. Thon, J.D.,PhD
  • General Counsel and Secretary
  • 2.34M

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
The9 Ltd
NCTY
13.1500
BIT Mining
BTCM
1.870
FRMO CORP
FRMO
8.505
4
Digihost Technology
DGHI
1.320
5
Abits
ABTS
3.200
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings